Table 3 Risk factors for the acquisition of secondary infection
From: Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation
Risk factors | n = 94 | Odds ratio (95% CI) | P value |
|---|---|---|---|
Demographics | |||
Age (years)—median [IQR]2 | 70 (62–77) | 0.96 (0.92–1.01) | 0.13 |
Male gender—no. (%) | 55 (59%) | 0.41 (0.17–0.99) | 0.05 |
BMI—median [IQR]2 | 27.5 (24.2–30.8) | 1.007 (0.926–1.095) | 0.87 |
Diabetes mellitus—no. (%) | 32 (34%) | 0.37 (0.15–0.91) | 0.03 |
Hypertension—no. (%) | 58 (62%) | 0.48 (0.19–1.24) | 0.13 |
Smoking—no. (%) | 4 (4%) | 1.12 (0.13–9.93) | 0.92 |
Characteristics of type and severity of illness | |||
APACHE IV score—median [IQR]2 | 46 (35–57) | 0.99 (0.96–1.02) | 0.35 |
SOFA score on admission—median [IQR]2 | 3 (2–5) | 1.14 (0.96–1.35) | 0.13 |
Hemodynamic assist device—no. (%) | 4 (4%) | 4.54 (0.17–122.37) | 0.37 |
Treatment | |||
Corticosteroids dose—median [IQR]2 | 0 (0–384) | 1.004 (1.001–1.007) | 0.004 |
Other immunosuppressive therapies*—no. (%) | 7 (7%) | 0.59 (0.12–2.78) | 0.50 |